X0306 4 2015-04-07 1 0001488613 Foundation Medicine, Inc. FMI 0001505781 Kleiner Perkins Caufield & Byers XIV, LLC 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 0001546196 KPCB XIV Associates, LLC C/O KLEINER PERKINS CAUFIELD BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 0001546197 KPCB XIV Founders Fund, LLC C/O KLEINER PERKINS CAUFIELD BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 Common Stock 2015-04-07 4 U 0 2100328 50.00 D 502309 D Common Stock 2015-04-07 4 U 0 177684 50.00 D 42495 D The amount reported represents the estimated number of shares sold by the reporting person in connection with the tender offer for shares of Common Stock of the Issuer (the "Tender Offer") by Roche Holdings, Inc. ("Roche"). Roche will purchase only a prorated portion of the shares properly tendered by each tendering stockholder. Based on a preliminary count reported by Roche, the preliminary proration factor for the Tender Offer is approximately 80.7%. If necessary, an amended Form 4 will be filed to report the number of shares actually sold by the reporting person in connection with the Tender Offer once the final proration factor is determined. The shares are directly held by Kleiner Perkins Caufield & Byers XIV, LLC ("KPCB XIV"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIV is KPCB XIV Associates, LLC ("XIV Associates"). The voting and dispositive control over the shares is shared by individual managing members of XIV Associates, none of whom has veto power. The shares are directly held by KPCB XIV Founders Fund, LLC. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIV Founders Fund, LLC is XIV Associates. The voting and dispositive control over the shares is shared by individual managing members of XIV Associates, none of whom has veto power. The reporting persons disclaim beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the reporting persons are the beneficial owners of these shares for purposes of Section 16 or for any other purpose. /s/ Paul Vronsky as Attorney-In-Fact for Kleiner Perkins Caufield & Byers XIV, LLC 2015-04-09 Paul Vronsky as Attorney-In-Fact for KPCB XIV Associates, LLC 2015-04-09 Paul Vronsky as Attorney-In-Fact for KPCB XIV Founders Fund, LLC 2015-04-09